Insight

Erika Hamilton: Vepdegestrant Outperforms Fulvestrant in Advanced ER+HER2− Breast Cancer

Erika Hamilton/LinkedIn

Aug 20, 2025, 14:45

Erika Hamilton: Vepdegestrant Outperforms Fulvestrant in Advanced ER+HER2− Breast Cancer

Erika Hamilton, Chair, Executive Committee Breast and Breast Program Lead at Sarah Cannon Research Institute, shared on LinkedIn about a recent paper by Patrick Neven et al. published on Nature:

“Great review of the vepdegestrant data presented at ASCO25 as well as the current status of the field post-1L CD4/6 inhibitor.”

Title: PROTAC SERD vepdegestrant outperforms fulvestrant for advanced-stage ER+HER2− breast cancer harbouring acquired ESR1 mutations

Authors: Patrick Neven and Sileny N. Han

Read the full article.

Erika Hamilton

Breast Cancer cancer Erika Hamilton OncoDaily Oncology

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding

Matt Sherer: ASCO Supports Permanent Medicare Telehealth

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Insight

Aug 20, 2025, 14:45

Erika Hamilton: Vepdegestrant Outperforms Fulvestrant in Advanced ER+HER2− Breast Cancer

Insight

Aug 20, 2025, 14:33

Tatiana Prowell: New FDA Draft Guidance on Overall Survival in Oncology Clinical Trials

Science

Aug 20, 2025, 14:25

Brian Kim Shared a New Paper on Peripheral Neuroimmune Mechanisms of Tissue Restoration

Insight

Aug 20, 2025, 14:24

Kohei Shitara: Final OS analysis of KN585

Voices

Aug 20, 2025, 14:12

NACLC25: Where Leading Clinicians, Researchers and Advocates Unite to Advance Lung Cancer Care - IASLC

Voices

Aug 20, 2025, 14:12

EACR- The Mark Foundation for Cancer Research Postdoctoral Fellowship

Voices

Aug 20, 2025, 14:02

Wade Swenson: Excited to Speak at NOC2025 on Rural Cancer Care

Insight

Aug 20, 2025, 13:59

Jeremy L Davis: Spatial Analysis of Hereditary Diffuse Gastric Cancer

Voices

Aug 20, 2025, 13:51

Amy Moore: National Patient Advocacy Day

Insight

Aug 20, 2025, 13:46

Hassan R Hashmi: Important Insight from JAMA Surgery

Voices

Aug 20, 2025, 13:40

Pleased to Welcome Natasha Madsen Shah as the New Executive Director of the Access to Oncology Medicines Coalition - UICC

Voices

Aug 20, 2025, 13:31

Rasha Aboelhassan: Productive Cancer Treatment Discussion with Oncology Department